Navigation Links
Hoya Announces Third Quarter and the First Nine Months Financial Results for FY2008

TOKYO, February 5 /PRNewswire-FirstCall/ -- HOYA Corporation today announced financial results for the third quarter ended December 31, 2008. Net sales were 112.7 billion yen for the quarter, representing a decrease of 23.3% from 147.0 billion yen in the third quarter of 2007, mainly due to order decrease and the drop in the product price resulting from global economic downturn in the main business fields such as the Electro-Optics and Vision Care, as well as PENTAX that was included in the scope of consolidation during the same period of the previous year.

Operating income for the third quarter fell 39.4%, to 16.6 billion yen, and net income was down 44.2%, to 12.6 billion yen. Earnings per share for the quarter were 29.13 yen compared with 52.22 yen in the third quarter of 2007.

For the first nine months ended December 31, 2008, the company posted a 7.4% increase in net sales over the same period of 2007, to 371.2 billion yen, however, operating income fell 23.2% to 59.1 billion yen, and net income was down 12.8%, to 52.9 billion yen. Earnings per share were 122.31 yen compared with 140.48 yen in the first nine months of 2007.

"Global economic downturn continues to have a negative impact on the Electro-Optics business in this quarter," said Hiroshi Hamada, chief operating officer of HOYA. "However, our medical field is little-affected; especially our endoscopic system business under Pentax brand showed double-digit growth on a local currency bases. We will accelerate structural reforms and at the same time, pursue selective investment and strategic marketing in all fields."

The full quarterly report is available in "Financial Statement" page in HOYA website Investor Relations section at:

*Results are preliminary and unaudited.

*The yen amounts shown therein are rounded down to the nearest 100 million.

About Hoya Corporation

Hoya Corporation is a global technology company based in Tokyo, Japan, and the leading supplier of innovative and indispensable high-tech products and services based upon its advanced optics technologies. Hoya is active in four fields of business: The Eye Care provides eyeglasses, operates retail shops for contact lenses, and makes intraocular lenses for cataract surgery. The Life Care provides endoscopic system. Electro-Optics makes mask blanks and photomasks for the semiconductor devices and LCD panels, optical lenses for digital cameras, and glass memory disks for HDDs. The Imaging produces SLR/compact digital cameras, interchangeable lenses, lens modules and microlenses. Hoya now has over 80 subsidiaries and affiliates, and employs approximately 38,000 people worldwide.

    Contact Information:

    Akiko Maeyama / Naoji Ito
    Corporate Communications
    Hoya Group
    Tel: +81-3-3232-0065

SOURCE Hoya Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
(Date:10/9/2015)... ROCKVILLE, Md. , Oct. 9, ... biotechnology company developing next generation vaccines based on ... entered into an exclusive worldwide licensing agreement with ... treatment or prevention of any and all allergic ... Immunomic Therapeutics will receive an upfront payment of ...
(Date:10/9/2015)... ... , ... Leading microbial genomics startup uBiome today launched the first-ever microbiome app, ... management and the microbiome. The study uses the ResearchKit framework, designed by Apple, to ... The uBiome app is available as a free download from the App Store. The ...
(Date:10/8/2015)... 8, 2015  Genetic testing for mutations beyond those ... of more couples at risk of having a child ... at the 2015 American Society of Human Genetics (ASHG) ... Baltimore, Maryland . The study is one ... DGX ) are presenting at the conference this week ...
(Date:10/8/2015)... .   ... Goldman Small Cap Research, a stock market research ... sectors, announced today that it has published a ... (OTCQB - PMCB), a publicly traded, clinical stage ... for cancer and diabetes. To view the sponsored ...
Breaking Biology Technology:
(Date:10/12/2015)... 2015 Hoyos Labs ... company, will introduce its new biometric four-finger ... simultaneously, providing an unprecedented level of security ... the new biometric standard for secure transactions ... from financial services to healthcare are implementing ...
(Date:10/12/2015)... DUBLIN , Oct. 12, 2015 ... the addition of the "Iris Recognition Market ... Others), Application (Access Control & Others), Industry (Travel ... Geography Global - Forecast to 2020" report ... --> Iris Recognition Market worth ...
(Date:10/8/2015)... Oct. 8, 2015 Synaptics Inc. (NASDAQ: ... solutions, announced today that it will report financial ... on Thursday, October 22, 2015, after the close ... conference call for analysts and investors at 2:00 ... may discuss forward-looking information. ...
Breaking Biology News(10 mins):